FDA Clearance Tracker · K221832
SABER .014 PTA Dilatation Catheter; SABERX .014 PTA Dilatation Catheter
Last checked: Nov 19, 2026Latest source record: Aug 22, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Aug 22, 2022
Substantially Equivalent
Time to decision
60 days
Received Jun 23, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K221832
- Device name
- SABER .014 PTA Dilatation Catheter; SABERX .014 PTA Dilatation Catheter
- Applicant
- Cordis US Corp
- Applicant location
- Miami Lakes, FL
- Received
- Jun 23, 2022
- Decided
- Aug 22, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1250
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LIT. The earliest in FDA's data is K803057, decided Jan 13, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K221832
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Cordis US Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K233637 · Decided Jun 28, 2024 · 228 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
K232573 · Decided Nov 21, 2023 · 88 days after receipt
Device type: Catheter, Intravascular, Diagnostic (DQO) · Cardiology
P220004 · Decided Jul 21, 2023 · 466 days after receipt
Device type: Pulmonary stent (QWC) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.